Kraig Biocraft Laboratories Launches Performance Yarn Development Program and Ships Spider Silk to Yarn and Aerospace Innovator
A recent custom yarn sale to a performance apparel customer provides the starting point for the broader development effort.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Kraig Biocraft Laboratories (KBLB) launched a performance yarn development program and shipped spider silk samples to a yarn technology firm. The program builds on a recent sale and shipment of custom yarn to a performance apparel customer. It will develop new yarn constructions and material blends for fabrics, apparel and other materials.
The sample recipient requested the shipment and has experience collaborating with tier-1 aerospace manufacturers on materials development. Kraig Labs expects the program to support multiple commercialization paths, potentially including collaborations with brands, mills and manufacturers, as well as its own apparel development.
Positive
- Minor pointCustom yarn sale and shipment to a performance apparel customer provides a commercial foundation.
- Minor point. Forward-looking: it has not happened yet and may not happen.New development program plans yarn constructions and material blends for fabrics, apparel and other materials.
- Minor pointSpider silk samples shipped at the recipient’s request to a firm with aerospace materials collaboration experience.
- Minor point. Forward-looking: it has not happened yet and may not happen.Kraig Labs expects multiple commercialization paths, potentially including industry collaborations and its own apparel development.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Initiative Builds on First Commercial Yarn Shipment to Create New Constructions and Blends for the Next Generation of Fabrics and Apparel
ANN ARBOR, Mich., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced the launch of a new program to develop innovative performance yarns built on its recombinant spider silk. The Company also announced that it has shipped samples of its spider silk to an innovative firm with a history of collaborating with tier-1 aerospace manufacturers to develop new materials. The yarn development program builds directly on the Company’s recent sale and shipment of a custom yarn to a performance apparel customer.
The program has a clear purpose; Kraig Labs will develop new yarn constructions and new material blends. These yarns will be designed from the ground up to enable new fabrics, new apparel, and new materials. Each one will leverage the performance and the rarity of spider silk.
Kraig Labs’ first custom yarn proved the process and opened the door to a broader effort and opportunities to bring innovation in materials performance from the lab to the market.
“Our first custom yarn showed that it is now possible to produce and deliver spider silk to industry,” said Kim Thompson, Founder and CEO of Kraig Labs. “This program takes that further. We are launching the development of new yarns, new constructions, and new blends. Each one is built around the performance and capabilities of spider silk.”
The Company expects the program to serve as the groundwork for multiple commercialization paths, potentially including new collaborations with brands, mills, and manufacturers, to Kraig Labs’ own innovation in apparel.
This initial shipment was sent out at the request of this innovator in textiles. The recipient is known for developing some of the world’s most advanced yarn spinning equipment. Their expertise and leadership in this space has earned their place in collaboration alongside tier-1 aerospace manufacturers to develop next gen fibers and hybrid structures. Their work is centered where strength, weight, and performance decide outcomes. This shipment puts recombinant spider silk in front of a team with deep experience in demanding applications.
“Spider silk is a material that will earn its place through performance,” Thompson said. “Sending samples of our silk to a firm with this background puts it in front of people who know exactly how to leverage materials with exceptional performance. Every great fabric starts with a yarn. This program is where we build that foundation.”
The Company’s leadership in biomaterials was recently spotlighted on the cover of the March 2026 issue of National Geographic, highlighting the growing importance and predominance of our work in scaling spider silk production.
Interested persons can order a copy of National Geographic featuring Kraig Labs at https://ngsingleissues.nationalgeographic.com/natgeo-march-2026.
You can purchase a digital copy of the article directly from National Geographic at https://www.nationalgeographic.com/science/article/spider-silk-silkworm-genetic-engineering.
You can see Kraig Labs featured in Veritasium’s spider silk video at https://www.youtube.com/watch?v=wt4p2oalmRY.
For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.
For details about recent Kraig Labs advancements, please watch the Company’s investor updates at www.kraiglabs.com/videos or on the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.
* For a description of our historical leadership in this technology, please follow this link https://www.kraiglabs.com/world-leader/
Kraig Labs Technology is built on a scientifically engineered silkworm, which incorporates key spider silk proteins to produce recombinant spider silk.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward-looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, Inc.
(720) 288-8495
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is Kraig Biocraft Laboratories developing through its new yarn program?
Kraig Labs plans to develop new yarn constructions and material blends using its recombinant spider silk. The program builds on a recent custom yarn sale and shipment to a performance apparel customer.
Who received Kraig Biocraft Laboratories’ spider silk samples?
The samples went to an unnamed yarn technology firm that requested them. The recipient develops yarn spinning equipment and has collaborated with tier-1 aerospace manufacturers on new fibers and hybrid structures.